Barber TJ - Search Results

1

Screening for HIV-related neurocognitive impairment in clinical practice: challenges and opportunities.

Barber TJ, Bradshaw D, Hughes D, Leonidou L, Margetts A, Ratcliffe D, Thornton S, Pozniak A, Asboe D, Mandalia S, Boffito M, Davies N, Gazzard B, Catalan J. Barber TJ, et al. AIDS Care. 2014 Feb;26(2):160-8. doi: 10.1080/09540121.2013.819401. Epub 2013 Jul 22. AIDS Care. 2014. PMID: 23869661 Review.

2

How does HIV impact on non-AIDS events in the era of HAART?

Barber TJ, Hughes A, Dinsmore WW, Phillips A. Barber TJ, et al. Int J STD AIDS. 2009 Jan;20(1):1-3. doi: 10.1258/ijsa.2008.008302. Int J STD AIDS. 2009. PMID: 19103883 Review.

3

Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study.

Barber TJ, Geretti AM, Anderson J, Schwenk A, Phillips AN, Bansi L, Gilson R, Hill T, Walsh J, Fisher M, Johnson M, Post F, Easterbrook P, Gazzard B, Palfreeman A, Orkin C, Leen C, Gompels M, Dunn D, Delpech V, Pillay D, Sabin CA; UK CHIC Study Steering Committee. Barber TJ, et al. Antivir Ther. 2011;16(6):805-14. doi: 10.3851/IMP1818. Antivir Ther. 2011. PMID: 21900712

4

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor.

Barber TJ, Harrison L, Asboe D, Williams I, Kirk S, Gilson R, Bansi L, Pillay D, Dunn D; UK HIV Drug Resistance Database and UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees. Barber TJ, et al. J Antimicrob Chemother. 2012 Apr;67(4):995-1000. doi: 10.1093/jac/dkr569. Epub 2012 Jan 17. J Antimicrob Chemother. 2012. PMID: 22258921

5

HIV-associated neurocognitive disease: case studies and suggestions for diagnosis and management in different patient subgroups.

Pozniak A, Rackstraw S, Deayton J, Barber T, Taylor S, Manji H, Melvin D, Croston M, Nightingale S, Kulasegaram R, Pitkanen M, Winston A. Pozniak A, et al. Antivir Ther. 2014;19(1):1-13. doi: 10.3851/IMP2563. Epub 2013 Mar 21. Antivir Ther. 2014. PMID: 23519006 Review.

6

Nightingale A, Ratcliffe D, Leonidou L, Margetts A, Asboe D, Gazzard B, Catalan J, Barber TJ. Nightingale A, et al. Among authors: barber tj. AIDS Care. 2014;26(8):1036-41. doi: 10.1080/09540121.2014.894619. Epub 2014 Mar 13. AIDS Care. 2014. PMID: 24625218

7

Assessing the role of peripheral CD8 T cells in neurocognitive impairment in HIV-infected men who have sex with men: data from the MSM Neurocog Study.

Rawson TM, Dubb S, Pozniak A, Kelleher WP, Mandalia S, Gazzard B, Barber TJ. Rawson TM, et al. Among authors: barber tj. Int J STD AIDS. 2015 Feb;26(2):128-32. doi: 10.1177/0956462414531934. Epub 2014 Apr 22. Int J STD AIDS. 2015. PMID: 24759562

8

Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor.

Barber T, Hill A, Singh GJ, Boffito M, Nelson M, Moyle G. Barber T, et al. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19562. doi: 10.7448/IAS.17.4.19562. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25394069 Free PMC article.

9

Effect of hyperbilirubinaemia on neurocognitive, renal, bone and cardiovascular markers in HIV infection treated with boosted protease inhibitors.

Barber TJ, Moyle G, Hill A, Singh GJ, Boffito M, Nelson M. Barber TJ, et al. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19827. doi: 10.7448/IAS.17.4.19827. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397571 Free PMC article.

10

FLAMINGO: still in the pink?

Barber TJ, Pozniak A. Barber TJ, et al. Lancet HIV. 2015 Apr;2(4):e116-7. doi: 10.1016/S2352-3018(15)00037-5. Epub 2015 Mar 10. Lancet HIV. 2015. PMID: 26424668 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page